The DNAbilize revolution is starting. Whatever you may think of Peter, he is the only one who has been successful making antisense therapy work. The interim report is another benchmark demonstrating that DNAbilize, the lipid delivery system, has the capability of providing many many therapies against other cancers as well as other diseases. Each one a new revenue stream for the company. Look up all the micro cap bio stocks that have been financed 100% by Maxim and cronies. You will see that ALL of them have been decimated, so Peter is not alone. The shorters are in control only because they have deep pockets and know how to take advantage of investors who believe in young bio companies struggling to find break-through remedies to subdue suffering. I would think your ire should be more against the naked shorters who are messing with your money than Peter who is just trying to cure cancer. The company has shown they really have something that will be big. The question is; will all the spoils go to the shorters or are there enough buyers out there to squeeze them dry. Anyway, I just wanted to give another perspective.